SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-060465
Filing Date
2020-03-03
Accepted
2020-03-03 16:16:42
Documents
13
Period of Report
2020-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d865747d8k.htm   iXBRL 8-K 39367
2 EX-4.1 d865747dex41.htm EX-4.1 851876
  Complete submission text file 0001193125-20-060465.txt   1203346

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20200302.xsd EX-101.SCH 3056
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20200302_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20200302_pre.xml EX-101.PRE 10943
14 EXTRACTED XBRL INSTANCE DOCUMENT d865747d8k_htm.xml XML 3222
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 20682462
SIC: 2834 Pharmaceutical Preparations